primary outcome measure

primary outcome measure

(1) The specific key measurement(s) or observation(s) used to measure the effect of experimental variables in a study, or for observational studies, to describe patterns of diseases or traits or associations with exposures, risk factors or treatment.
(2) The outcome measure or measures in a clinical trial which have the greatest or most desirable therapeutic effect.
References in periodicals archive ?
The primary outcome measure will assess the effect of apabetalone on time to first occurrence of Major Adverse Cardiovascular Events (MACE) in high-risk type 2 DM patients with CAD.
Tabular representation for phase I drug candidates and phase II drug candidates has been provided, which summarizes information about promising drug candidates under clinical trials and associated conditions, sponsors and collaborators, primary outcome measure, time frame, and status about designated safety issue.
The primary outcome measure was the incidence of ischaemic heart disease in the intervention group compared with that in the control group.
The primary outcome measure of the study was the time to first relapse event in the double-blind phase of the study.
The primary outcome measure was body-mass index (BMI), and secondary outcomes included eating disorder psychopathology, anxiety, and depression.
The primary outcome measure was improvement on MMAS scores after 2 years of follow-up.
The primary outcome measure for the study was the relative changes in hypothalamic regional cerebral blood flow (CBF) after glucose or fructose ingestion.
Preterm delivery (<37 wk) was the primary outcome measure whereas late preterm (>34 wk <37), moderately preterm (>32 wk <34) and early preterm delivery (<32 wk) were used as secondary outcomes.
The primary outcome measure is improvement in oxygenation on day three post-operatively, while secondary outcomes to be assessed will include degree of atelectasis on chest xray, ICU and hospital length of stay; patient comfort during oxygen therapy; and mortality and incidence of respiratory complications up to day 28 post-operatively.
the primary outcome measure in the cognitive domain was the change in the total score of the SKT test battery, an internationally and cross-culturally validated measure to test cognitive performance in dementia.
The primary outcome measure was ongoing pregnancy rate per cycle.